Nearly 16 million U.S. patients underwent nuclear imaging procedures in 2007, according to a report by marketing research firm IMV Medical Information Division. The figure shows a 3% jump compared with the 15.2 million patients who had a nuclear medicine exam back in 2006.
Nearly 16 million U.S. patients underwent nuclear imaging procedures in 2007, according to a report by marketing research firm IMV Medical Information Division. The figure shows a 3% jump compared with the 15.2 million patients who had a nuclear medicine exam back in 2006.
Approximately 15.7 million patients underwent these procedures in 7320 hospital and nonhospital sites during 2007. The figure represents a small but noticeable increase compared with a similar report released last year by the Des Plaines, IL, company. The previous report had found that the number of exams performed during 2006 had dropped 12% from 17.2 million patient visits recorded for 2005.
Several factors accounted for the earlier decrease, according to IMV senior director of market research Lorna Young. Health insurance companies are stepping up precertification requirements for nuclear medicine procedures. Hybrid imaging modalities have brought about turf encroachment.
About nine in 10 PET exams have been traditionally dedicated to oncology. After the introduction of PET/CT, many oncology procedures that used to be the exclusive purview of nuclear medicine began falling into the hands of competing subspecialties.
IMV analysts suggest that nuclear medicine utilization may again increase in 2008, rising to about 16 million procedures, Young said. IMV Medical Information Division released the report Nov. 10.
These safe and cost-effective techniques provide a wealth of useful information to help shape a patient's treatment plan. To ensure that these tests meet patient demand, however, the U.S. must create a reliable domestic supply of medical isotopes, said SNM President Dr. Robert Atcher.
"As this report demonstrates, nuclear medicine and molecular imaging procedures are essential elements of today's medical practice," Atcher told Diagnostic Imaging.
Report findings show:
IMV Medical Information Division, founded in 1977, specializes in medical imaging and other advanced healthcare technology markets. Its Market Summary Reports include interventional angiography, radiographic fluoroscopy, cardiac catheterization, CT, MRI, nuclear medicine, echocardiography, PET, radiation oncology, x-ray/DR/CR, and mammography.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.